As host and head of content for Radio Advisory, Rachel (also known as “Rae”) plans and prioritizes episodes based on the most pressing challenges of the day. As host, Rae interviews industry experts, breaking down the top issues executives should be thinking about and eliciting the actionable next steps healthcare leaders should take.
Rachel (Rae) Woods has hosted 173 Episodes.
-
200: Why 2024 is a make-or-break year for corporate medical groups
March 19th, 2024 | 32 mins 40 secs
consolidation, physician landscape
In this episode, host Rae Woods invites Advisory Board physician experts Sarah Roller and Eliza Dailey to discuss why 2024 will be a make-or-break year for corporate medical groups, and what that means for the rest of the industry.
-
198: PE firm General Catalyst is buying a hospital — here's our take
March 5th, 2024 | 35 mins 5 secs
consolidation, disruption, financial impact
In this episode, host Rachel Woods and co-host Abby Burns bring back Advisory Board health system expert Vidal Seegobin to interpret the news that venture capitalist firm General Catalyst intends to acquire Summa Health. We've long said “no one is buying hospitals” – have we been wrong?
-
196: The future of surgery (no, it's not just robots)
February 20th, 2024 | 32 mins 27 secs
In this episode, host Rachel Woods invites Advisory Board experts Isis Monteiro, Miles Cottier, and Paul Trigonoplos to discuss how innovation is shaping surgical care (hint: it's not just robots performing procedures) and what it will actually take to see health systems reclaim their margins.
-
194: The patients are not all right: Unpacking the quality crisis with The Joint Commission's Dr. David Baker
February 6th, 2024 | 39 mins 53 secs
In this episode, host Rachel Woods talks with Darby Sullivan, Advisory Board's equity expert, about the state of clinical quality. She also speaks with Dr. David Baker, Executive Vice President for Healthcare Quality Evaluation and Improvement at The Joint Commission, to discuss why patient quality is declining and what the industry can do to improve it.
-
193: Is health system growth still possible?
January 30th, 2024 | 33 mins 21 secs
financial impact
In this episode, host Rachel Woods invites Advisory Board health systems expert Vidal Seegobin, and quantitative insights expert Larry Watts to discuss why heath systems might have to first shrink in order to grow and stabilize their business for the future.
-
192: What CEOs need to know in 2024 (Part 2)
January 23rd, 2024 | 28 mins 33 secs
strategy
In this episode host Rachel Woods continues her conversation with Advisory Board experts Natalie Trebes, Prianca Pai, and Sharon Yuen about what should be on CEOs radar in 2024, with a focus on changes in who delivers care and how it’s paid for.
-
191: What CEOs need to know in 2024 (Part 1)
January 16th, 2024 | 32 mins 33 secs
strategy
In this episode, host Rachel Woods invites Advisory Board experts Natalie Trebes, Prianca Pai, and Sharon Yuen to discuss the industry changes that healthcare leaders need to know now and prepare for in 2024.
-
190: Behind the scenes with Rae & AskAdvisory
December 19th, 2023 | 29 mins 57 secs
In this episode, host Rachel Woods invites AskAdvisory experts to answer our listener’s most pressing questions. Then, she wraps up the year by giving listeners a behind-the-scenes look at what goes into making this podcast.
-
189: A preview of Advisory Board's 2024 research
December 12th, 2023 | 24 mins 57 secs
clinical workforce, strategy, technology, value-based care
In this episode, host Rachel Woods invites 11 Advisory Board experts to discuss what's on their radar – and what should be on yours, too – as we approach 2024.
-
188: The business case for investing in women's health
December 5th, 2023 | 32 mins 34 secs
Host Rachel Woods invites Advisory Board's Gaby Marmolejos, Kara Marlatt, and Ellie Wiles to discuss the financial imperative and opportunities of investing in holistic women's health.
-
186: The new era of drugs is now
November 21st, 2023 | 26 mins 4 secs
In this episode, host Rachel Woods invites Advisory Board pharmacy experts Rachel Peroutky and Chloe Bakst to discuss how stakeholders should be preparing themselves for the new era of pharmaceutical drugs.
-
185: AI adoption: why you can't afford to "wait and see"
November 14th, 2023 | 26 mins 47 secs
technology
In this episode, host Rachel Woods invites Advisory Board digital health experts Ty Aderhold and Elysia Culver to discuss the advantages and disadvantages of being an early mover or fast follower of AI, and how the industry needs to be thinking about AI adoption and integration.